Showing posts with label uveitis. Show all posts
Showing posts with label uveitis. Show all posts

Wednesday, September 16, 2026

New focus on ocular inflammation and possible therapeutic pathways

A new study published in The American Journal of Pathology provides new evidence that immune cells enter the retina via the body's standard pathway, identifying Platelet Endothelial Cell Adhesion Molecule (PECAM; also known as CD31) as the gatekeeper and neutrophils as proresolving mediators. This research offers new insights into how eye inflammation develops and could lead to better-targeted treatment options.

Wednesday, September 23, 2020

COVID-19 and the Retina - how does this Coronavirus affect the back of the eye?

(c) Wikipedia
COVID-19 can affect the retina. Retinal vein diameter seems directly correlated with the disease severity. Its assessment could have possible applications in the management of COVID-19.

As the coronavirus pandemic evolves and spreads worldwide, more information emerges on how the virus affects the body. What was once a respiratory illness has now become a systemic infection, affecting multiple organs.

Monday, March 5, 2018

Clearside's CLS-TA achieves endpoints in Phase 3 PEACHTREE trial

(c) Retinal Physician
Clearside Biomedical, Inc. has announced positive topline results from its pivotal Phase 3 clinical trial of suprachoroidal CLS-TA in patients with macular edema associated with non-infectious uveitis.